Skip to main content
SpringerLink
Log in

Therapeutic Applications of Nuclear Medicine

  • Chapter
  • First Online:
A Concise Guide to Nuclear Medicine

  • 1126 Accesses

Abstract

Therapeutic applications of nuclear medicine are expanding (Table 11.1). The radioisotopes in therapy were limited predominantly to treatment of hyperthyroidism and thyroid cancer, and polycythemia rubra vera for many years. Strontium 89 (Sr-89), rhenium 186 (Re-186), samarium 153 (Sm-153), and tin 117 m (Sn-117) have been increasingly used recently in treating bone pain secondary to metastases. Additionally, treatment of certain neuroendocrine tumors with I-131 MIBG and labeled octreotide and pentreotide, the use of radiolabeled monoclonal antibodies for lymphomas, and radionuclide synovectomy has revolutionized the field of therapeutic nuclear medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Brans B, Bacher K, Vandevyver V, Vanlangenhove P, Smeets P, Thierens H, Dierckx RA et al (2003) Intra-arterial radionuclide therapy for liver tumors: effect of selectivity of catheterization and 131I-Lipiodol delivery on tumor uptake and response. Nucl Med Commun 24:391–396

    Article  PubMed  CAS  Google Scholar 

  • Elgazzar AH (2006) Therapeutic nuclear medicine. In: Elgazzar AH (ed) Pathophysiologic basis of nuclear medicine, 2nd edn. Springer, Berlin

    Chapter  Google Scholar 

  • Iagaru A, McDougall IR (2007) Treatment of thyrotoxicosis. J Nucl Med 48:379–389

    PubMed  CAS  Google Scholar 

  • Mothersill C et al (2006) Targeted radiotherapy: is the “holy grail” in sight? J Nucl Med 47:27N–27N

    Google Scholar 

  • Shankar LK et al (2006) Consensus recommendations for the use of F-18 FDG PET as an indicator of therapeutic response in patients in national cancer institute trials. J Nucl Med 47:1059–1066

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kuwait, Kuwait

    Abdelhamid H. Elgazzar MD., FCAP

Authors
  1. Abdelhamid H. Elgazzar MD., FCAP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdelhamid H. Elgazzar MD., FCAP .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Elgazzar, A.H. (2011). Therapeutic Applications of Nuclear Medicine. In: A Concise Guide to Nuclear Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19426-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-19426-9_11

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-19425-2

  • Online ISBN: 978-3-642-19426-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation